Open Access

Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice

Event: ESC Congress 2018
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Sponsored by Boehringer Ingelheim
Date: 27 August 2018
Time: 13:00 - 14:00

Session

5 presentations in this session

NOACs: key features on safety, continuity, and reversibility.

Speaker: Professor E. Hylek (Boston, US)
Thumbnail

Unlocking the data: interpreting real-world evidence to inform treatment decisions.

Speaker: Professor T. Villines (Charlottesville, US)
Thumbnail

GLORIA-AF: latest results from this prospective study.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Reversal matters: comprehensive care with dabigatran and idarucizumab.

Speaker: Professor H. Darius (Berlin, DE)
Thumbnail

Panel discussion and Q&A - Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice.

Speaker: Professor E. Hylek (Boston, US)
Speaker: Professor H. Darius (Berlin, DE)
Thumbnail

6 speakers from this session

Professor Elaine Hylek

Boston University, Boston (United States of America)
10 presentations
0 follower

Professor Todd Villines

University of Virginia, Charlottesville (United States of America)
7 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
61 presentations
3 followers

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
10 presentations
0 follower

Professor Elaine Hylek

Boston University, Boston (United States of America)
10 presentations
0 follower

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
10 presentations
0 follower

This platform is supported by

logo Novo Nordisk